Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DuPont de Nemours
DD
|
+$1.55B |
| 2 |
Comcast
CMCSA
|
+$449M |
| 3 |
SLB Ltd
SLB
|
+$298M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$281M |
| 5 |
Qualcomm
QCOM
|
+$228M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$229M |
| 2 |
Sempra
SRE
|
+$192M |
| 3 |
Bausch Health
BHC
|
+$183M |
| 4 |
BNY
Bank of New York Mellon
BNY
|
+$175M |
| 5 |
PepsiCo
PEP
|
+$173M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 12.58% |
| 2 | Energy | 11.62% |
| 3 | Consumer Discretionary | 8.89% |
| 4 | Financials | 8.63% |
| 5 | Technology | 8.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
876
G-III Apparel Group
GIII
$1.43B
| $11.1M | 0.02% |
179,646
+89,314
| +99% | +$6.13M |
|
|
CHMA
877
DELISTED
Chiasma, Inc. Common Stock
CHMA
| $11.1M | 0.02% |
+556,655
| New | +$13.8M |
|
|
NRF
878
DELISTED
NorthStar Realty Finance Corp.
NRF
| $11M | 0.02% |
446,818
+217,195
| +95% | +$6.46M |
|
879
SunCoke Energy
SXC
$816M
| $11M | 0.02% |
1,411,423
-1,537,390
| -52% | -$17.1M |
|
880
Public Service Enterprise Group
PEG
$36.6B
| $11M | 0.02% |
260,446
-256,290
| -50% | -$10.5M |
|
|
NTRI
881
DELISTED
NutriSystem, Inc.
NTRI
| $11M | 0.02% |
+413,689
| New | +$11.3M |
|
|
CMRX
882
DELISTED
Chimerix, Inc.
CMRX
| $11M | 0.02% |
286,752
+113,181
| +65% | +$5.59M |
|
883
PUT
Parker-Hannifin
PH
$128B
| $10.9M | 0.02% |
+112,500
| New | +$12.2M |
|
884
Gray Television
GTN
$507M
| $10.9M | 0.02% |
855,818
+303,278
| +55% | +$4.31M |
|
885
CALL
Valero Energy
VLO
$99.6B
| $10.9M | 0.02% |
181,200
| – | – |
|
886
BioCryst Pharmaceuticals
BCRX
$2.47B
| $10.9M | 0.02% |
954,888
-962,133
| -50% | -$12.8M |
|
|
FCE.A
887
DELISTED
Forest City Realty Trust, Inc.
FCE.A
| $10.9M | 0.02% |
540,772
+509,190
| +1,612% | +$11.2M |
|
|
WBMD
888
DELISTED
WebMD Health Corp.
WBMD
| $10.9M | 0.02% |
272,767
+111,093
| +69% | +$4.7M |
|
|
AFSI
889
DELISTED
AmTrust Financial Services, Inc.
AFSI
| $10.9M | 0.02% |
344,810
+295,944
| +606% | +$9.38M |
|
890
Avery Dennison
AVY
$13.9B
| $10.9M | 0.02% |
191,883
-10,666
| -5% | -$644K |
|
|
SNCR
891
DELISTED
Synchronoss Technologies
SNCR
| $10.8M | 0.02% |
+36,672
| New | +$14.2M |
|
892
Karyopharm Therapeutics
KPTI
$42.2M
| $10.8M | 0.02% |
68,382
+44,085
| +181% | +$11.8M |
|
|
AMED
893
DELISTED
Amedisys
AMED
| $10.8M | 0.02% |
283,357
-262,725
| -48% | -$11.1M |
|
|
894
CALL
Qualcomm
QCOM
$166B
| $10.7M | 0.02% |
200,000
+100,000
| +100% | +$5.94M |
|
895
Goodyear
GT
$1.73B
| $10.7M | 0.02% |
+365,890
| New | +$11M |
|
896
Capri Holdings
CPRI
$1.55B
| $10.7M | 0.02% |
252,471
-554,551
| -69% | -$23.5M |
|
897
NETGEAR
NTGR
$563M
| $10.6M | 0.02% |
+363,707
| New | +$11.1M |
|
|
898
CALL
DuPont de Nemours
DD
$18.5B
| $10.6M | 0.02% |
98,720
+59,232
| +150% | +$6.86M |
|
899
Pacific Biosciences
PACB
$398M
| $10.6M | 0.02% |
2,895,705
-548,762
| -16% | -$2.68M |
|
|
EMWP
900
DELISTED
Eros Media World PLC
EMWP
| $10.6M | 0.02% |
19,420
+17,966
| +1,236% | +$11.5M |
|
Similar funds
Israel Englander's Q3 2015 Portfolio in Review
As of Q3 2015, Israel Englander held 4,098 positions worth $51.6B, down 2.3% from $52.9B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Israel Englander deployed $5.12B of net new capital in Q3 2015, opening 839 new positions and adding to 1,320 existing holdings. Its largest new stake was BP: 4,551,492 shares worth $117M.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, down from 15% a quarter earlier, followed by Energy and Consumer Discretionary.
On the sell side, the largest reduction was Alexion Pharmaceuticals, an estimated $229M trimmed.
- Israel Englander's largest Q3 2015 buy was BP: 4,551,492 shares worth $117M.
- Israel Englander added most to DuPont de Nemours in Q3 2015, an estimated $1.55B increase.
- Israel Englander's biggest Q3 2015 reduction was Alexion Pharmaceuticals, cutting an estimated $229M.
- Israel Englander fully exited PepsiCo in Q3 2015, selling an estimated $173M.
- Israel Englander's ten largest holdings make up 14% of its $51.6B portfolio in Q3 2015.
- Israel Englander opened 839 new positions and closed 681 in Q3 2015.
- Israel Englander's portfolio value fell 2.3% quarter-over-quarter to $51.6B.
Based on Millennium Management's 13F filing for Q3 2015, filed 16 Nov 2015.